Solar Pharmaceutical Industries Ltd.’s revenue declined within the fourth quarter of fiscal yr 2024-25, thereby lacking the estimates shared by analysts.
India’s largest drugmaker’s consolidated internet revenue fell 19% year-on-year to Rs 2,154 crore within the March quarter, in line with an alternate submitting on Thursday. That compares with the Rs 2,794-crore consensus estimate of analysts tracked by Bloomberg.
This text was written byComply withCharles Rotblut, CFA is the editor of the AAII Journal, the flagship publication of The...
India expects Turkiye to strongly urge Pakistan to finish its assist to cross-border terrorism, mentioned Ministry of Exterior Affairs (MEA)...
State-run ONGC reported a 20 per cent year-on-year (y-o-y) decline in its consolidated web revenue to ₹8,856 crore throughout This...
"As you rightly talked about rubber costs have been sort of easing off in latest occasions and because of this,...
This text was written byObserveRick is a Wall Road Journal best-selling writer with over 20 years of expertise buying and...
Tariffs, tariffs, tariffs. That’s what’s been on each enterprise proprietor’s and shopper’s thoughts for the reason that February 2025 announcement...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
